The replacement of the double bond of ceramide by a cyclopropene (for example, erythro-1) has resulted in the first potent inhibitor of dihydroceramide desaturase, which is a key enzyme in the biosynthesis of sphingolipids.
No takes yet. Share an insight, caveat, or question.
Triola et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: